rs369058619
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001113378.2(FANCI):c.3946G>A(p.Gly1316Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000261 in 1,611,664 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G1316E) has been classified as Likely benign.
Frequency
Consequence
NM_001113378.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FANCI | NM_001113378.2 | c.3946G>A | p.Gly1316Arg | missense_variant | 38/38 | ENST00000310775.12 | |
POLG | NM_002693.3 | c.*333C>T | 3_prime_UTR_variant | 23/23 | ENST00000268124.11 | ||
POLGARF | NM_001406557.1 | c.*3325C>T | 3_prime_UTR_variant | 23/23 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FANCI | ENST00000310775.12 | c.3946G>A | p.Gly1316Arg | missense_variant | 38/38 | 1 | NM_001113378.2 | P1 | |
POLG | ENST00000268124.11 | c.*333C>T | 3_prime_UTR_variant | 23/23 | 1 | NM_002693.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152062Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000646 AC: 16AN: 247504Hom.: 0 AF XY: 0.0000598 AC XY: 8AN XY: 133866
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1459602Hom.: 0 Cov.: 31 AF XY: 0.0000165 AC XY: 12AN XY: 726000
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152062Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74288
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | AiLife Diagnostics, AiLife Diagnostics | Jun 11, 2021 | - - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Fanconi anemia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 08, 2022 | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 1316 of the FANCI protein (p.Gly1316Arg). This variant is present in population databases (rs369058619, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with FANCI-related conditions. This missense change has been observed to co-occur in individuals with a different variant in FANCI that has been determined to be pathogenic (Invitae), but the significance of this finding is unclear. ClinVar contains an entry for this variant (Variation ID: 408231). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The arginine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Fanconi anemia complementation group I Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at